CALL US AT: (949) 396-0330

NEMUS Bioscience, Inc.

NEMUS Bioscience Inc. is a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids.


Cannabinoids are a class of chemically diverse compounds that are extracted from the cannabis plant. These compounds express their physiological response by binding to specific cannabinoid receptors (CB1 and CB2), which are found throughout the body. The spectrum of available research suggests that some cannabinoids exert multiple effects on the human body, including but not limited to: impacting the immune response, nervous system function and repair, gastrointestinal maintenance and motility, motor function in muscles, pancreatic functionality and blood sugar regulation, and integrity of function in the eye, including the optic nerve. Cannabinoid molecules have been studied widely, and published data point to the potential efficacy of these compounds in treating many disorders or alleviating disease-associated symptoms.

Known Effects of Cannabinoids


  • Cannabinoids are a class of diverse chemical compounds that are extracted from the Cannabis plant.
  • Cannabinoids act specifically through CB1 and CB2 receptors. These receptors are found throughout the body and are involved in many physiological processes.
  • Cannabinoids can specifically have impacts on the immune system, nervous system and the body’s organs.


  • There are 6 key cannabis extracts (of over 100) that have been shown to produce pharmacodynamic effects through their affinity for CB1 and CB2 receptors as shown in the chart to the right.

The Non-Psychotropic Effects of Plant Derived Cannabinoids

Image Reference: Izzo AA, et al. Trends in Pharmacologic Sciences, 2009; 30(10): 515-527

Drug Pipeline

  1. IMS Midas data; 2015
  2. Transparency Market Research, 2014
  3. Transparency Market Research, 2016
  4. Pew Trust MRSA Survey, 2012